1. Age-related macular degeneration and blindness due to neovascular maculopathy;Ferris;Arch Ophthalmol,1984
2. New treatment modalities for neovascular age-related macular degeneration;Schlottmann;Asia Pac J Ophthalmol (Phila),2017
3. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration;Li;Cochrane Database Syst Rev,2020
4. Ten years of anti-vascular endothelial growth factor therapy;Ferrara;Nat Rev Drug Discov,2016
5. Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): a systematic review and network meta-analysis of direct comparative studies;Plyukhova;J Clin Med,2020